Brief: Dr Reddy's Says Alvotech And Dr. Reddy's Enter Into Collaboration
05/06/2025 04:06
June 5 (Reuters) - Dr Reddy's Laboratories Ltd REDY.NS: ALVOTECH AND DR. REDDY’S ENTER INTO COLLABORATION COLLABORATION TO CO-DEVELOP BIOSIMILAR CANDIDATE TO KEYTRUDA (PEMBROLIZUMAB) Source text: ID:nnAZN3XV13C Further company coverage: REDY.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alvotech SA
See all newsBrief: CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program
Brief: Alvotech and Teva Secure U.S. Settlement Date For AVT06
India's Dr Reddy's rises after EU marketing authorisation for osteoporosis biosimilar
Brief: UK High Court Rules In Favor Of Alvotech Paving Way For AVT06, Biosimilar To Eylea
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm